Targeted Magnetic Nanoparticles for Clinical Imaging

Information

  • Research Project
  • 7115605
  • ApplicationId
    7115605
  • Core Project Number
    R44RR020233
  • Full Project Number
    4R44RR020233-02
  • Serial Number
    20233
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/24/2004 - 20 years ago
  • Project End Date
    8/31/2007 - 17 years ago
  • Program Officer Name
    LIU, GUOYING
  • Budget Start Date
    9/30/2005 - 19 years ago
  • Budget End Date
    8/31/2006 - 18 years ago
  • Fiscal Year
    2005
  • Support Year
    2
  • Suffix
  • Award Notice Date
    9/28/2005 - 19 years ago
Organizations

Targeted Magnetic Nanoparticles for Clinical Imaging

[unreadable] DESCRIPTION (provided by applicant): [unreadable] VisEn Medical, Inc. is proposing to develop novel targeted imaging probes for molecular imaging in small animals and human applications. The technology platform to be investigated in the application is based on novel iron oxide nanoparticles developed for target specific magnetic resonance imaging (MRI). VisEn Medical, Inc. has developed a class of novel magnetic nanoparticles, characterized by 1) extremely high stability achieved through "pseudocaging", 2) high magnetic relaxivity, 3) high efficiency targeting achieved through multivalency coupling of small molecule targeting ligands and 4) detectability by optical means through conjugation of high quantum yield near-infrared fluorochromes. These materials (pseudocaged nanoparticles or PNPs) are expected to have superior characteristics compared to dextran coated iron oxide nanoparticles currently in clinical and preclinical use, and are specifically designed to lead to the next generation of MRI agents with molecular specificity. The overall goal of Phase I of this proposal is to develop the technology platform that will enable development of the next generation of targeted PNPs for MRI. Specifically, we will systematically characterize three lead PNPs differing in size, characterize their physicochemical properties and test their cellular behavior. [unreadable] [unreadable]

IC Name
NATIONAL CENTER FOR RESEARCH RESOURCES
  • Activity
    R44
  • Administering IC
    RR
  • Application Type
    4
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    330576
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    389
  • Ed Inst. Type
  • Funding ICs
    NCRR:330576\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    VISEN MEDICAL, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    BEDFORD
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    017302314
  • Organization District
    UNITED STATES